WhatsApp
backNews Article

Suraksha Diagnostic Limited Announces Unaudited Financial Results for Q2 and H1 Ending September 30, 2026

Board approved standalone and consolidated financial results; limited review report issued by statutory auditors

Suraksha Diagnostic Limited has released its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with the limited review report by statutory auditors as per SEBI Listing Regulations.

10 Nov 2026|SURAKSHA-1.73%
Suraksha Diagnostic Limited544293SURAKSHAFinancial Results

Suraksha Diagnostic Limited

Financial Results

Suraksha Diagnostic Limited has approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, accompanied by a limited review report from the statutory auditors.

The Board of Directors met on November 10, 2026, and considered the unaudited financial results for both standalone and consolidated accounts for Q2 and H1 period of the fiscal year ending September 30, 2026.

These financial results have been subjected to a limited review by the Company's statutory auditors as required under SEBI Listing Regulations.

The company has made these results available on its website www.surakshanet.com for wider accessibility to investors and stakeholders.

The Board meeting began at 3:00 PM IST and concluded at 3:40 PM IST on the same day.

Highlights

  • Unaudited financial results for Q2 and H1 ended September 30, 2026 approved by the Board.
  • Results cover both standalone and consolidated financial statements.
  • Limited review report issued by statutory auditors accompanies the results.
  • Results available on Suraksha Diagnostic Limited's official website.
  • Board meeting held on November 10, 2026, lasted 40 minutes.

Key Data Snapshot

Reporting periodQuarter and Half Year ended September 30, 2026
Type of resultsUnaudited Standalone and Consolidated Financial Results
Board meeting date10th November, 2026
Review reportLimited Review Report by Statutory Auditors
Board meeting duration3:00 P.M. to 3:40 P.M. IST

What happened

  • Suraksha Diagnostic Limited's Board of Directors approved the unaudited financial results for the quarter and half year ended September 30, 2026.
  • The approval covers both standalone and consolidated financial statements.
  • The meeting took place on November 10, 2026, and lasted 40 minutes.

Key details

  • Results accompanied by a Limited Review Report issued by the statutory auditors as per SEBI Listing Regulations.
  • Results have been uploaded to the company’s official website for public access.
  • The company follows SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Regulatory and governance context

  • Announcement made under Regulation 30 and Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
  • Intimation includes Part A of Schedule III, ensuring compliance with disclosure norms.

More News on Financial Results

View all

Latest corporate announcements and market updates in Financial Results.

View all news
Suraksha Diagnostic Limited Announces Unaudited | Stockk News